Home
JournalsCollections
For Authors For Reviewers For Editorial Board Members
Article Processing Charges Open Access
Ethics Advertising Policy
Editorial Policy Resource Center
Company Information Contact Us
OPEN ACCESS

Magnesium Supplementation with Special Reference to Alcohol-Related Conditions: Experience from Russia

  • Sergei V. Jargin* 
Future Integrative Medicine   2022;1(1):38-42

doi: 10.14218/FIM.2022.00016

Received:

Revised:

Accepted:

Published online:

 Author information

Citation: Jargin SV. Magnesium Supplementation with Special Reference to Alcohol-Related Conditions: Experience from Russia. Future Integr Med. 2022;1(1):38-42. doi: 10.14218/FIM.2022.00016.

Abstract

Intravenous infusions of magnesium-containing solutions were routinely applied in Russia as treatment of alcohol withdrawal syndrome and other alcohol-related conditions. However, this indiscriminate approach is unfounded and may cause more harm than benefit. Magnesium deficiency is associated with certain circulatory, neuropsychiatric and metabolic conditions. The frequency of hypomagnesemia is enhanced in cases of chronic alcoholism. However, moderate deficiency does not necessarily require parenteral magnesium supplementation. Iatrogenic hypermagnesemia is associated with adverse effects. Endovascular manipulations in conditions of suboptimal procedural quality assurance can cause transmission of viral hepatitis. To decide if an intravenous magnesium supplementation is indicated, it should first be determined whether there is a deficiency and, if so, whether it can be compensated by diet or by oral intake of magnesium-containing drugs.

Keywords

Magnesium, Alcoholism, Alcohol withdrawal syndrome, Hypomagnesemia, Nutrition

Magnesium (Mg) is an intracellular cation involved in ATP metabolism. Mg is an essential element required as a cofactor for numerous enzymatic reactions and is necessary for the biochemical functioning of many metabolic pathways.1 Various foods and drinking water are sources of Mg.2 Chlorophyll, as found in green vegetables, is rich in magnesium. In cases of adequate nutrition, Mg deficiencies are unlikely.2,3 However, in cases of poor diet, Mg deficiencies are common.

Mg deficiency has been associated with certain circulatory, metabolic and neuropsychiatric conditions, arterial hypertension, and alcoholism. Some drugs such as antibiotics, diuretics, digitalis, and others may cause Mg wasting.2–14 Mg deficiency can develop in renal and gastrointestinal disease (Table 1).1–7,15,16 The frequency of hypomagnesemia among inpatients was estimated to range from 7–11%3,16 or 9–65% according to another review, and these statistics are higher in intensive care units.7 The prevalence of hypermagnesemia among inpatients was estimated to be in the range 5.7–9.3%, associated with increased mortality.7,11 The incidence was report to be 17% in the emergency room of one study.17 Mild Mg depletion does not necessarily require supplementation. Indications for prophylactic Mg intake by large population strata are questionable because of the risk of hypermagnesemia associated with adverse effects.18–21 Both low and excessive serum Mg concentrations may be unfavorable for osseous metabolism.20,22 High Mg concentrations have been shown to stimulate osteoclasts and inhibit osteoblast differentiation in vitro.18,23 Another study demonstrated that Mg consumption above the recommended dietary allowance was associated with an elevated risk of fractures.24 For example in one study, postmenopausal women in the upper quintile of Mg consumption had a greater risk of wrist fracture.19,20 Hypermagnesemia may also contribute to osteomalacia in renal failure, adynamic bone disease, and other disorders.3,11,22

Table 1

Causes of Mg deficiency

CategoriesDescriptions
Reduced dietary intakePoor food choices, malnutrition, demineralized water.1,3,5,7
Reduced gastrointestinal absorptionBowel diseases and resection, malabsorption, vitamin D deficiency, drugs.3,5
Increased losses from gastrointestinal tractDiarrhea, vomiting, laxative use.3,5
Increased renal lossesCongenital or acquired tubular defects, reduced reabsorption in old age, alcoholism, drugs.35
Endocrine and electrolyte derangementsDiabetes mellitus, primary hyperparathyroidism, hyperthyroidism, hyperaldosteronism, Bartter syndrome, severe burns, hypocalcaemia, phosphate depletion.3,5,6
Drug-inducedDiuretics, proton pump inhibitors, beta adrenergic agonists, certain antibiotics, antivirals, antifungals, antacids, chemotherapeutic agents, corticosteroids and some other hormones, phenytoin, phenobarbital, hydralazine, digoxin, pamidronate etc.1,2,3,5,6
Increased requirementsGrowth, pregnancy, lactation, continuous stress, heat, prolonged exercise.1,3,6,7,16
OthersAging is often associated with Mg deficit.1,4
Chronic latent Mg deficiency in various clinical conditions.6
Excessive sweating.16
Mg-free intravenous infusions.3,7
Genetic causes.3,5,6

Many studies have found enhanced frequency of hypomagnesemia in alcoholism or alcohol-related liver disease, and the potential underlying mechanisms are reported to inadequate nutrition, malabsorption, diarrhea, vomiting, and increased renal excretion.6,12,13,16 The prevalence of hypomagnesemia among chronic alcoholics was estimated at ∼30%3,25,26 or higher.27,28 An inverse relationship between serum concentrations of Mg and ethanol was found in healthy volunteers consuming alcohol.29 However, a study of 60 alcoholic men could not confirm a statistically significant reduction in Mg levels, with Mg levels reported to be within the normal range irrespective of the duration of alcohol consumption and abstinence.30 In a study of 129 alcohol-dependent individuals, 84 had normal, 37 had decreased, and 8 had excessive blood magnesium concentrations.9 High-risk patients, such as those with chronic diarrhea, receiving parenteral nutrition or diuretics, and those who are habitual alcohol consumers, should have their blood Mg checked and supplemented when indicated.2,3 Reportedly, Mg treatment may accelerated a decrease in serum aspartate-aminotransferase in patients with alcohol withdrawal symptoms, thus decreasing the risk of alcoholic liver disease.31 At the same time, the recommended therapy of Mg depletion in patients with alcoholic liver cirrhosis does not significantly differ from that of other Mg-depleted patients.13

According to a recent systematic review,32 no study has thus far investigated the management of Mg depletion in chronic alcohol-use disorders. Hypomagnesemia is mostly mild presenting with minimal or no symptoms. After intravenous administration, only a small portion of Mg is retained, as most is excreted in the urine.33 This is one reason why oral supplementation is preferable.32 Oral administration is safer, being associated with a lower risk of hypermagnesemia.34 Intravenous replacement may be required for symptomatic cardiac arrhythmias such as torsade de pointes or neuromuscular irritability.35 Excessive intravenous infusions of Mg can lead to hypermagnesemia in alcohol-dependent patients. Fatal iatrogenic overdoses of intravenous Mg in patients with alcohol withdrawal have been reported; the life-threatening manifestations include cardiac conduction delays, asystole, apnea, and coma.36 The difference between hangover and alcohol withdrawal syndrome should be considered. Although combinations are possible, a hangover is different from withdrawal syndrome, as the latter is a consequence of neuroadaptation to prolonged consumption.37 In a hangover there is residual ethanol intoxication with circulating levels of ethanol’s metabolites. Although withdrawal syndrome may resemble a hangover, it often presents with more pronounced and variegated symptoms in combination with alcohol cravings.38,39 It should be be noted that hangover and withdrawal syndromes have not been clearly distinguished from each other in the former Soviet Union.39,40

The recommended duration of detoxifying treatment including intravenous infusions was 5–10 days, and even 10–12 days according to some recommendations.41,42 It is common knowledge that alcohol and its derivatives are discharged spontaneously and dehydration can be compensated by an oral intake of liquids. Nonetheless, the following therapies were recommended and used to treat alcohol withdrawal syndrome: intravenous infusions of Mg sulfate, sodium thiosulfate, sodium chloride, glucose, and other solutions (7–10 infusions per day, sometimes combined with intramuscular or subcutaneous injections).43–47 Detoxification therapy was deemed “indicated for almost all alcoholic patients, especially to those with prolonged withdrawal syndrome”.41 Infusion therapy has been also recommended for patients with withdrawal syndrome of moderate severity.43 Similar indications can be found in recent publications.48,49 Certain methods were patented, including infusion therapy and transcerebral electrophoresis of Mg-containing solutions as therapies for alcohol withdrawal syndrome.46,50–52 Intramuscular injections have also been recommended, including Mg sulfate, glucose, sodium thiosulfate solutions, subcutaneous infusions of saline, extracorporeal ultraviolet irradiation of blood, sorbent hemo- and lympho-perfusion, “cerebrospinal fluid perfusion”, or “liquorosorption”.42,47,53–56 Admittedly, some withdrawal symptoms are similar to those observed in Mg deficiency and may improve with supplementation. Among others, thiamine utilization in patients with alcohol withdrawal syndrome may be positively influenced by an adequate Mg status.27 However, patients without Mg deficiency can develop the syndrome while delirium tremens may discontinue despite persistently low Mg levels.57 Hypomagnesemia may persist for 2 weeks after the onset of abstinence, potentially justifying a nutrient supplementation,58 but indiscriminate intravenous infusions could be contraindicated. The prescription of Mg for alcohol withdrawal including delirium tremens has been debated, and as such there is insufficient evidence to prescribe Mg in this setting.32,34 Controlled trials have not demonstrated improvements in severity of alcohol withdrawal, delirium, or seizures with Mg use.59 According to one Cochrane review, there is no sufficient evidence to administer Mg to treat or prevent alcohol withdrawal syndrome.60

Mg should be supplemented in cases of proven hypomagnesemia. In case of clinical indications, infusion therapy may be administered with monitoring of renal function and Mg levels.59 There is an opinion that Mg infusions “can only be envisaged in intensive care units with careful monitoring of pulse, arterial pressure, deep tendon reflexes, hourly diuresis, electrocardiogram and respiratory recordings”.61 The guidelines recommend checking electrolyte levels and correcting abnormalities where necessary,60 or “in case of biological deprivation”.34 Despite limitations, Mg serum levels are used as a standard assessment of Mg status.3,7 Blood Mg levels can revert to normal levels at the time of delirium onset.13,62 In the above-cited study, hypomagnesemia was detected in 42.3% of delirium tremens patients;9 and other researchers have reported comparable or even higher rates.63,64 Given that withdrawal syndrome may be hard to distinguishe from Wernicke encephalopathy, oral Mg was recommended for severe cases;65 but intravenous infusions in alcohol withdrawal syndrome have not been recommended.62 It should be stressed that lengthy drip infusions are associated with discomfort. Some alcoholic patients considered such treatments as punishment; this motivation was apparently present among some medics.66 It should be noted that repeated endovascular procedures may result in a transmission of hepatitis B and C, which has occurred in patients with chronic alcoholism. A combination of viral and alcohol-related liver injury is known to be associated with less favorable prognosis. The nosocomial transmission of hepatitis virus is a known problem. Thus, the reuse of injection equipment should be avoided.67 There are preventive measures that can be applied in the healthcare settings.68 In the absence of disposable needles and syringes, reusable instruments must be properly sterilized. However, this has not always been the case in some institutions. Unfortunately, attitudes towards alcoholic patients can be negative, resulting in potentially lower procedural quality assurance. Therefore, indications for intravenous and other invasive manipulations should be thoroughly evaluated.

Outdated and suboptimal methods have sometimes been applied in the former SU due to partial isolation from the international professional community, insufficient adherence to the principle of informed consent, paternalistic attitudes towards patients, lack of professional autonomy, autocratic or military managerial style discouraging criticism, and impartial polemics.69,70 Suboptimal practices have been applied as per instructed and according to leading expert publications, and some examples have been discussed previously.70,71 In brief, the overuse of Halsted and Patey mastectomy with excision of pectoral muscles, routine electrocoagulation of cervical ectropions without cyto- or histo-logical examination for precancerous changes, extensive gastric resections for peptic ulcers, thoracic and abdominal surgery for bronchial asthma and diabetes mellitus,70 overuse of surgery in tuberculosis (Tb),71 mass bronchoscopy in conscripts with supposed pneumonia.72,73 Some invasive methods with questionable indications were introduced or advocated by first generation military surgeons.70 There is an opinion, that over-manipulation has sometimes been applied with the aim of personnel training. Alcohol-dependent people are convenient subjects of such treatments. Finally, it should be noted that patients suffering both Tb and alcoholism are often subject to the treatment described above. In some cases, vocal cord injuries were observed in such patients after repeated bronchoscopies due to suboptimal procedural quality assurance. It was reported that apomorphine-induced vomiting as emetic (aversive) therapy of alcohol dependence provoked hemoptysis.41 In some official instructions, indications for surgery were broader in alcoholics than in other Tb patients;55 surgery was recommended earlier, after a shorter period of medical therapy.74 Reportedly, in 1994 about 60% of patients in a “phtisio-narcological” institution who were receiving compulsory treatment absconded and half were brought back by the police (militia).75 The duration of compulsory treatment in such institutions was around one year or longer.42 During the 1990s, the system of compulsory treatment was largely dismantled, but some experts recommended a return to the Soviet-time practices of compulsory treatment.76 More details can be found in another review.71

Conclusions

Patients with alcohol withdrawal syndrome and other alcohol-related conditions have been routinely treated in Russia by intravenous infusions of Mg-containing solutions. This sometimes entailed unfavorable physiological and psychological effects. Significant Mg deficiency should not be a priori assumed in all alcoholics.77 To decide if a parenteral Mg supplementation is indicated, it should first be determined whether there is a Mg deficiency and, if so, whether it can be compensated by diet or by oral intake of Mg-containing drugs or dietary supplements. More research on the effects of exogenous Mg in alcohol-related disorders is needed, including withdrawal syndrome and delirium tremens, taking into account blood Mg levels and other indices such as Mg content in red blood cells, loading test, and 24-h urinary excretion.

Abbreviations

ATP: 

adenosine triphosphate

Mg: 

magnesium

SU: 

Soviet Union

S-AST: 

serum aspartate-aminotransferase

Tb: 

tuberculosis

Declarations

Acknowledgement

None.

Funding

None.

Conflict of interest

The author has no conflict of interests related to this publication.

Authors’ contributions

Single author (SVJ): Concept and design, writing, and approval of the manuscript.

References

  1. Schwalfenberg GK, Genuis SJ. The Importance of Magnesium in Clinical Healthcare. Scientifica (Cairo) 2017;2017:4179326 View Article PubMed/NCBI
  2. Gröber U, Schmidt J, Kisters K. Magnesium in Prevention and Therapy. Nutrients 2015;7(9):8199-8226 View Article PubMed/NCBI
  3. Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev 2003;24(2):47-66 View Article PubMed/NCBI
  4. Barbagallo M, Veronese N, Dominguez LJ. Magnesium in Aging, Health and Diseases. Nutrients 2021;13(2):463 View Article PubMed/NCBI
  5. de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev 2015;95(1):1-46 View Article PubMed/NCBI
  6. Romani AM. Magnesium in health and disease. Met Ions Life Sci 2013;13:49-79 View Article PubMed/NCBI
  7. Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J ;2012(Suppl 1):i3-i14 View Article PubMed/NCBI
  8. Trapani V, Rosanoff A, Baniasadi S, Barbagallo M, Castiglioni S, Guerrero-Romero F, et al. The relevance of magnesium homeostasis in COVID-19. Eur J Nutr 2022;61(2):625-636 View Article PubMed/NCBI
  9. Stasiukinene VP, Pilvinis VK, Reĭngardene DI. Hypomagnesemia in patients with chronic alcoholism in the course of alcohol withdrawal syndrome (in Russian). Ter Arkh 2004;76(11):97-99 View Article PubMed/NCBI
  10. Volpe SL. Magnesium in disease prevention and overall health. Adv Nutr 2013;4(3):378S-383S View Article PubMed/NCBI
  11. Castiglioni S. Editorial of Special Issue “Magnesium in Human Health and Disease”. Nutrients 2021;13(8):2490 View Article PubMed/NCBI
  12. Magarian GJ, Lucas LM, Kumar KL. Clinical significance in alcoholic patients of commonly encountered laboratory test results. West J Med 1992;156(3):287-294 View Article PubMed/NCBI
  13. Lieber CS. Medical and nutritional complications of alcoholism: mechanisms and management. New York: Springer; 1992 View Article PubMed/NCBI
  14. Kostov K. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling. Int J Mol Sci 2019;20(6):E1351 View Article PubMed/NCBI
  15. Wang J, Um P, Dickerman BA, Liu J. Zinc, Magnesium, Selenium and Depression: A Review of the Evidence, Potential Mechanisms and Implications. Nutrients 2018;10(5):E584 View Article PubMed/NCBI
  16. Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth 1999;83(2):302-320 View Article PubMed/NCBI
  17. Rauchenzauner M, Kountchev J, Ulmer H, Pechlaner C, Bellmann R, Wiedermann CJ, et al. Disturbances of electrolytes and blood chemistry in acute alcohol intoxication. Wien Klin Wochenschr 2005;117(3):83-91 View Article PubMed/NCBI
  18. Leidi M, Dellera F, Mariotti M, Maier JA. High magnesium inhibits human osteoblast differentiation in vitro. Magnes Res 2011;24(1):1-6 View Article PubMed/NCBI
  19. Nieves JW. Skeletal effects of nutrients and nutraceuticals, beyond calcium and vitamin D. Osteoporos Int. 2013;24(3):771-786 View Article PubMed/NCBI
  20. Castiglioni S, Cazzaniga A, Albisetti W, Maier JA. Magnesium and osteoporosis: current state of knowledge and future research directions. Nutrients 2013;5(8):3022-3033 View Article PubMed/NCBI
  21. Mathew AA, Panonnummal R. ‘Magnesium’-the master cation-as a drug-possibilities and evidences. Biometals 2021;34(5):955-986 View Article PubMed/NCBI
  22. Navarro-González JF, Mora-Fernández C, García-Pérez J. Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Semin Dial 2009;22(1):37-44 View Article PubMed/NCBI
  23. Mammoli F, Castiglioni S, Parenti S, Cappadone C, Farruggia G, Iotti S, et al. Magnesium Is a Key Regulator of the Balance between Osteoclast and Osteoblast Differentiation in the Presence of Vitamin D3. Int J Mol Sci 2019;20(2):E385 View Article PubMed/NCBI
  24. Orchard TS, Larson JC, Alghothani N, Bout-Tabaku S, Cauley JA, Chen Z, et al. Magnesium intake, bone mineral density, and fractures: results from the Women’s Health Initiative Observational Study. Am J Clin Nutr 2014;99(4):926-933 View Article PubMed/NCBI
  25. Liamis GL, Milionis HJ, Rizos EC, Siamopoulos KC, Elisaf MS. Mechanisms of hyponatraemia in alcohol patients. Alcohol Alcohol 2000;35(6):612-616 View Article PubMed/NCBI
  26. Baj J, Flieger W, Teresiński G, Buszewicz G, Sitarz R, Forma A, et al. Magnesium, Calcium, Potassium, Sodium, Phosphorus, Selenium, Zinc, and Chromium Levels in Alcohol Use Disorder: A Review. J Clin Med 2020;9(6):E1901 View Article PubMed/NCBI
  27. Maguire D, Burns A, Talwar D, Catchpole A, Stefanowicz F, Ross DP, et al. Randomised trial of intravenous thiamine and/or magnesium sulphate administration on erythrocyte transketolase activity, lactate concentrations and alcohol withdrawal scores. Sci Rep 2022;12(1):6941 View Article PubMed/NCBI
  28. Grochowski C, Blicharska E, Baj J, Mierzwińska A, Brzozowska K, Forma A, et al. Serum iron, Magnesium, Copper, and Manganese Levels in Alcoholism: A Systematic Review. Molecules 2019;24(7):E1361 View Article PubMed/NCBI
  29. Petroianu A, Barquete J, Plentz EG, Bastos C, Maia DJ. Acute effects of alcohol ingestion on the human serum concentrations of calcium and magnesium. J Int Med Res 1991;19(5):410-413 View Article PubMed/NCBI
  30. Ayirolimeethal A, Jacob TR, George B, Kothamuttath P, Tharayil HM. Serum magnesium level and severity of delirium in alcohol withdrawal state. Open J Psychiatry Allied Sci 2019;10(2):120-123 View Article PubMed/NCBI
  31. Poikolainen K, Alho H. Magnesium treatment in alcoholics: a randomized clinical trial. Subst Abuse Treat Prev Policy 2008;3:1 View Article PubMed/NCBI
  32. Vanoni FO, Milani GP, Agostoni C, Treglia G, Faré PB, Camozzi P, et al. Magnesium Metabolism in Chronic Alcohol-Use Disorder: Meta-Analysis and Systematic Review. Nutrients 2021;13(6):1959 View Article PubMed/NCBI
  33. De Marchi S, Cecchin E, Basile A, Bertotti A, Nardini R, Bartoli E. Renal tubular dysfunction in chronic alcohol abuse—effects of abstinence. N Engl J Med 1993;329(26):1927-1934 View Article PubMed/NCBI
  34. Airagnes G, Ducoutumany G, Laffy-Beaufils B, Le Faou AL, Limosin F. Alcohol withdrawal syndrome management: Is there anything new?. Rev Med Interne 2019;40(6):373-379 View Article PubMed/NCBI
  35. Palmer BF, Clegg DJ. Electrolyte Disturbances in Patients with Chronic Alcohol-Use Disorder. N Engl J Med 2017;377(14):1368-1377 View Article PubMed/NCBI
  36. Vissers RJ, Purssell R. Iatrogenic magnesium overdose: two case reports. J Emerg Med 1996;14(2):187-191 View Article PubMed/NCBI
  37. Boness CL, Lane SP, Sher KJ. Assessment of Withdrawal and Hangover is Confounded in the Alcohol Use Disorder and Associated Disabilities Interview Schedule: Withdrawal Prevalence is Likely Inflated. Alcohol Clin Exp Res 2016;40(8):1691-1699 View Article PubMed/NCBI
  38. Palmer E, Tyacke R, Sastre M, Lingford-Hughes A, Nutt D, Ward RJ. Alcohol Hangover: Underlying Biochemical, Inflammatory and Neurochemical Mechanisms. Alcohol Alcohol 2019;54(3):196-203 View Article PubMed/NCBI
  39. Jargin SV. Some aspects of tobacco smoking in the context of alcohol drinking, hangover and mental health problem. International Journal of Psychiatry Research 2019;1(2):10-12 View Article PubMed/NCBI
  40. Jargin SV. Some aspects of tobacco smoking in the context of alcohol consumption and hangover. J Sci Discov 2020;4(2):jsd20030 View Article PubMed/NCBI
  41. Entin GM. Lechenie alkogolizma [Treatment of alcoholism] (in Russian). Moscow: Meditsina; 1990. Available from: https://search.rsl.ru/en/search#q=5225015891. Accessed July 19, 2022 View Article PubMed/NCBI
  42. Health Ministry of RSFSR. Combined treatment of patients with pulmonary tuberculosis suffering of alcoholism (in Russian). Moscow: Methodical Recommendations; 1989 View Article PubMed/NCBI
  43. Ivanets NN, Vinnikova MA. Alcoholism: doctor’s manual (in Russian). Moscow: MIA Publ; 2011 View Article PubMed/NCBI
  44. Shabanov PD. Narcology (in Russian). 2nd edition. Moscow: Geotar-Media; 2015 View Article PubMed/NCBI
  45. Annex to the Order of the Health Ministry of Russian Federation No. 140. [updated 1998 April 28]. Available from: http://docs.cntd.ru/document/1200119087. Accessed July 11, 2022 View Article PubMed/NCBI
  46. Galankin LN, Livanov GA, Guzikov BM, Volkov NIu, inventors. View Article PubMed/NCBI
  47. Nikitin IuP. Profilaktika i lechenie alkogolizma [Prevention and treatment of alcoholism] (in Russian). Kiev: Zdorov’ia; 1990. Available from: https://search.rsl.ru/en/search#q=5311025018. Accessed July 19, 2022 View Article PubMed/NCBI
  48. Gromova OA, Torshin IYu. Magnesium and diseases of civilization: a practical guide (in Russian). Moscow: Geotar-Media; 2018 View Article PubMed/NCBI
  49. Vinnikova MA, Krenkel’ NT, Tikov MS, Tsareva IS. Modern approaches to the treatment of severe alcohol withdrawal syndrome (guidelines) (in Russian). Moscow: Research and Practical Centre for Narcology of the Department of Public Health; 2018. Available from: https://narcologos.ru/111610. Accessed July 19, 2022 View Article PubMed/NCBI
  50. Sosin IK, Sema VI, Gurevich YL, Mysko GN, Slabunov OS, Palamarchuk VM, et al. View Article PubMed/NCBI
  51. Panin LE, inventor. View Article PubMed/NCBI
  52. Chitalov VG, Zhukova NE, inventors. View Article PubMed/NCBI
  53. Belskich AN. Current phase of extracorporeal haemocorrection and therapeutic apheresis development in medical military academy - clinical centre for extracorporeal detoxication (1988-2013). Efferent Therapy 2013;19(1):10-17 View Article PubMed/NCBI
  54. Syropiatov OG, Dzeruzhynskaia NA. Pathogenesis and biological therapy of alcoholism (in Russian). Kiev: Military Medical Academy; 2000 View Article PubMed/NCBI
  55. Health Ministry of Ukrainian SSR. Special features of detection, diagnosis, clinical course, treatment and prevention of tuberculosis in patients with chronic alcoholism (in Russian). Kiev: Methodical Recommendations; 1987 View Article PubMed/NCBI
  56. Garbusenko ON, Babashev BB, Salahanov RA. Ultraviolet irradiation of blood in therapy of acute alcohol abstinence syndrome (in Russian). Efferent Therapy 2013;19(1):98-99 View Article PubMed/NCBI
  57. Pitts TO, Van Thiel DH. Disorders of divalent ions and vitamin D metabolism in chronic alcoholism. Recent Dev Alcohol 1986;4:357-377 View Article PubMed/NCBI
  58. Prior PL, Vaz MJ, Ramos AC, Galduróz JC. Influence of microelement concentration on the intensity of alcohol withdrawal syndrome. Alcohol Alcohol 2015;50(2):152-156 View Article PubMed/NCBI
  59. Mayo-Smith MF, Beecher LH, Fischer TL, Gorelick DA, Guillaume JL, Hill A, et al. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med 2004;164(13):1405-1412 View Article PubMed/NCBI
  60. Sarai M, Tejani AM, Chan AH, Kuo IF, Li J. Magnesium for alcohol withdrawal. Cochrane Database Syst Rev ;2013:CD008358 View Article PubMed/NCBI
  61. Durlach J, Durlach V, Bac P, Bara M, Guiet-Bara A. Magnesium and therapeutics. Magnes Res 1994;7(3-4):313-328 View Article PubMed/NCBI
  62. Jermain DM, Crismon ML, Nisbet RB. Controversies over the use of magnesium sulfate in delirium tremens. Ann Pharmacother 1992;26(5):650-652 View Article PubMed/NCBI
  63. Elisaf MS, Siamopoulos KC. Disorders of water, electrolyte and acid-base balance in alcoholic patients. Clin Nephrol 1998;50(6):390 View Article PubMed/NCBI
  64. Wolfe SM, Victor M. The relationship of hypomagnesemia and alkalosis to alcohol withdrawal symptoms. Ann N Y Acad Sci 1969;162(2):973-984 View Article PubMed/NCBI
  65. Junghanns K, Wetterling T. Alcohol withdrawal and its major complications (in German). Fortschr Neurol Psychiatr 2017;85(3):163-177 View Article PubMed/NCBI
  66. Jargin SV. About the treatment of gonorrhea in the former Soviet Union. Dermatol Pract Concept 2012;2(3):12 View Article PubMed/NCBI
  67. Ozaras R, Tahan V. Acute hepatitis C: prevention and treatment. Expert Rev Anti Infect Ther 2009;7(3):351-361 View Article PubMed/NCBI
  68. Fitzsimons D, François G, Alpers K, Radun D, Hallauer J, Jilg W, et al. Prevention of viral hepatitis in the Nordic countries and Germany. Scand J Infect Dis 2005;37(8):549-560 View Article PubMed/NCBI
  69. Danishevski K, McKee M, Balabanova D. Variations in obstetric practice in Russia: a story of professional autonomy, isolation and limited evidence. Int J Health Plann Manage 2009;24(2):161-171 View Article PubMed/NCBI
  70. Jargin SV. Invasive procedures with questionable indications. Ann Med Surg (Lond) 2014;3(4):126-129 View Article PubMed/NCBI
  71. Jargin SV. Some aspects of the surgical and endoscopic treatment of tuberculosis in Russia. J Surgery 2021;9(1):1-8 View Article PubMed/NCBI
  72. Ismagilov NM. Complicated community-acquired pneumonia in young people from organized groups: clinical and morphological picture, diagnosis and treatment [Dissertation] (in Russian). Samara: Military Medical Institute; 2009 View Article PubMed/NCBI
  73. Kazantsev VA. View Article PubMed/NCBI
  74. Pilipchuk NS, Kharchenko EF, Ivaniuta OM. Tuberkulemy legkih, plevry i sredostenia [Tuberculomas of the lungs, pleura and mediastinum] (in Russian). Kiev: Zdorov’ia; 1974. Available from: https://www.rsl.ru/. Accessed July 19, 2022 View Article PubMed/NCBI
  75. Rudoi NM, Dzhokhadze VA, Chubakov TCh, Stadnikova AV. Current status and perspectives in hospital treatment of patients with tuberculosis complicated with alcohol abuse (in Russian). Probl Tuberk ;1994(4):8-10 View Article PubMed/NCBI
  76. Bogorodskaia EM, Ol’khovatskiĭ EM, Borisov SE. Legal aspects of compulsory hospitalization ofincompliant patients with tuberculosis (in Russian). Probl Tuberk Bolezn Legk ;2009(4):8-14 View Article PubMed/NCBI
  77. Jargin SV. Indications for magnesium supplementation an example of alcoholism (in Russian). Zh Nevrol Psikhiatr Im S S Korsakova 2022;122(5):118-122 View Article PubMed/NCBI